Biyong Ren

Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial

Li Li, Liyan Jiang, Yubo Wang et al. · Clinical Cancer Research · 2019 · 71 citations · Full text

Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer

Yunpeng Yang, Bin Wu, Linian Huang et al. · Translational Lung Cancer Research · 2019 · 35 citations · Full text

Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

Jie Xie, Jun Cao, Jingfen Wang et al. · Breast Cancer Research and Treatment · 2017 · 33 citations

Breast Oncology, Breast Cancer Patients, Medicine +6

Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: a multicenter, open-label, randomized, controlled phase III trial

Zhenzhou Yang, Yan Zhang, Rongqing Li et al. · Neuro-Oncology · 2020 · 27 citations · Full text

Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial

Zhonghan Zhang, Yunpeng Yang, Ping Lu et al. · Annals of Translational Medicine · 2020 · 13 citations · Full text